logo-loader

AMPEL BioSolutions focused on developing clinical blood test predicts the correct drug for a patient

Published: 13:42 15 Jan 2020 EST

AMPEL BioSolutions COO Dr Amrie Grammer chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Charlottesville, Virginia-based company can identify drugs for treating lupus patients. According to its website, the company's system can be applied to any disease.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

2 hours, 5 minutes ago